FIELD: chemistry.
SUBSTANCE: group of inventions relates to a compound of formula (I) or its enantiomer, diastereomer, racemate, solvate, hydrate or pharmaceutically acceptable salt:
also relates to a compound selected from compounds 1–187 and 189–376, or an enantiomer, diastereomer, racemate, solvate, hydrate or pharmaceutically acceptable salt thereof, also relates to a pharmaceutical composition for preventing and/or treating a disease or condition mediated by an aromatic hydrocarbon receptor (AhR) and to a pharmaceutical composition for inhibiting proliferation, tissue invasion, metastasis and angiogenesis of malignant tumour cells in a subject with a malignant tumour or cancer condition, also relates to a method of modulating AhR activity in a subject, a method for preventing or treating a disease or condition mediated by an aromatic hydrocarbon receptor (AhR) in a subject, and a method for inhibiting proliferation, tissue invasion, metastasis and angiogenesis of cancer cells in a subject with a malignant tumour or cancer condition.
EFFECT: group of inventions provides the development of compounds which have selective inhibitory action on AhR.
24 cl, 2 tbl, 376 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
COMPOUNDS AND A COMPOSITION FOR MODULATING THE KINASE ACTIVITY OF EGFR MUTANTS | 2015 |
|
RU2727700C2 |
TETRAHYDROPYRIDINE DERIVATIVES AND USE THEREOF AS ANTIBACTERIAL AGENTS | 2017 |
|
RU2722594C1 |
HETEROARYL DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A METHOD FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAID ACTIVE SUBSTANCE | 2016 |
|
RU2719367C2 |
NOVEL HETEROCYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2018 |
|
RU2733384C1 |
5-SUBSTITUTED INDAZOLE AS KINASE INHIBITORS | 2008 |
|
RU2487873C2 |
1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
NOVEL IMIDAZOLE DERIVATIVE HAVING JNK INHIBITORY ACTIVITY, AND USE THEREOF | 2017 |
|
RU2702749C1 |
COMPOUNDS AND COMPOSITIONS FOR MODULATING KINASE ACTIVITY OF EGFR MUTANTS | 2015 |
|
RU2822389C2 |
BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION | 2016 |
|
RU2729187C1 |
Authors
Dates
2024-09-16—Published
2021-03-29—Filed